ArticleHaematologica2021
CCND2 mutations are infrequent events in BCR-ABL1 negative myeloproliferative neoplasm patients.
Bruno Cassinat et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleHaematologica2021
Bruno Cassinat et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.